Amfenac (sodium)
Amfenac sodium (AHR 5850 sodium) is an orally active and potent anti-inflammatory compound possessing antipyretic and analgesic properties. Amfenac sodium can be used for the research of acute and chronic inflammation[1].
Product Specifications
CAS Number
[61941-56-8]
Product Name Alternative
AHR 5850 (sodium)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/amfenac-sodium.html
Purity
98.90
Smiles
O=C(CC1=C(N)C(C(C2=CC=CC=C2)=O)=CC=C1)O[Na]
Molecular Formula
C15H12NNaO3
Molecular Weight
277.25
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Sancilio LF, et al. AHR-5850: a potent anti-inflammatory compound. Agents Actions. 1977 Mar;7 (1) :133-44.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SPG20, CT (SPG20, KIAA0610, TAHCCP1, Spartin, Spastic paraplegia 20 protein, Trans-activated by hepatitis C virus core protein 1) (MaxLight 650) discontinued
CTNNB1 (Catenin beta-1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923, beta-Catenin) discontinued
CTNNB1 (Catenin beta-1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923, beta-Catenin) discontinued
CTNNB1 (Catenin beta-1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923, beta-Catenin) discontinued
